Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Wai-See Ma"'
Autor:
Eric Kalo, Scott Read, Asma Baig, Kate Marshall, Wai‐See Ma, Helen Crowther, Cameron Gofton, Kate D Lynch, Siddharth Sood, Jacinta Holmes, John Lubel, Alan Wigg, Geoff McCaughan, Stuart K Roberts, Paolo Caraceni, Golo Ahlenstiel, Avik Majumdar
Publikováno v:
JGH Open, Vol 8, Iss 9, Pp n/a-n/a (2024)
Abstract The current treatment approach to patients with liver cirrhosis relies on the individual management of complications. Consequently, there is an unmet need for an overall therapeutic strategy for primary and secondary prevention of complicati
Externí odkaz:
https://doaj.org/article/673d719f794442e6a9f9616d7b93020c
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Objective Delivering effective secondary preventive and integrated care has the potential to break the revolving-door phenomenon of frequent readmissions in patients with advanced chronic liver disease. To address this, we launched the Care
Externí odkaz:
https://doaj.org/article/f201a2d0bbd847d7856593e15575db30
Autor:
Maurizio Voi, Xiong Cai, Hai-Xiao Zhai, Mylissa Borek, Steven DellaRocca, Anna Wai See Ma, Brian Zifcak, Maria Samson, Ling Yin, Hui Qu, Ruzanna Atoyan, Guang-Xin Xu, Jing Wang, Da-Gong Wang, Rudi Bao, Cheng-Jung Lai, Changgeng Qian
PDF file, 348KB, Figure S1. Synergy between PI3K and HDAC pathway inhibition. Figure S2. CUDC-907 increases acetylation of histone H3 in cultured cancer cells. Figure S3. CUDC-907 increases tubulin acetylation in cultured cancer cells. Figure S4. CUD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32848b021e6bbc17f583b7bdf8d37c66
https://doi.org/10.1158/1078-0432.22445738.v1
https://doi.org/10.1158/1078-0432.22445738.v1
Autor:
Maurizio Voi, Xiong Cai, Hai-Xiao Zhai, Mylissa Borek, Steven DellaRocca, Anna Wai See Ma, Brian Zifcak, Maria Samson, Ling Yin, Hui Qu, Ruzanna Atoyan, Guang-Xin Xu, Jing Wang, Da-Gong Wang, Rudi Bao, Cheng-Jung Lai, Changgeng Qian
Purpose: Given that histone deacetylase (HDAC) inhibitors are known to induce multiple epigenetic modifications affecting signaling networks and act synergistically with phosphatidylinositol 3-kinase (PI3K) inhibitors, we developed a strategy to simu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57468279c708b76d5357a1cc33f8026e
https://doi.org/10.1158/1078-0432.c.6520553
https://doi.org/10.1158/1078-0432.c.6520553
Publikováno v:
Gastrointestinal Endoscopy. 91:AB518
Publikováno v:
Gastroenterology. 154:814-815
Autor:
Maurizio Voi, Guang-Xin Xu, Brian Zifcak, Anna Wai See Ma, Dagong Wang, Steven DellaRocca, Rudi Bao, Maria Samson, Cheng-Jung Lai, Hui Qu, Mylissa Borek, Haixiao Zhai, Ling Yin, Xiong Cai, Ruzanna Atoyan, Changgeng Qian, Jing Wang
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 18(15)
Purpose: Given that histone deacetylase (HDAC) inhibitors are known to induce multiple epigenetic modifications affecting signaling networks and act synergistically with phosphatidylinositol 3-kinase (PI3K) inhibitors, we developed a strategy to simu
Publikováno v:
Livers, Vol 4, Iss 2, Pp 182-192 (2024)
Non-invasive tests (NITs) are a potential alternative to screening oesophagogastroduodenoscopy (OGD) for ruling out high-risk varices (HRVs) in patients with compensated advanced chronic liver disease (cACLD). This retrospective study aimed to extern
Externí odkaz:
https://doaj.org/article/88d98d88316247da92c7b6c9679fce7c